---
title: "Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279874000.md"
description: "Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization"
datetime: "2026-03-20T02:08:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279874000.md)
  - [en](https://longbridge.com/en/news/279874000.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279874000.md)
---

# Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization

Hemostemix Raises $784,000 to Advance Stem Cell Therapy Commercialization

### Related Stocks

- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [426CVR015TMP.US](https://longbridge.com/en/quote/426CVR015TMP.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [David Malcom Rodman Sells 14,056 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock](https://longbridge.com/en/news/286410546.md)
- [GRI Bio Highlights Promising Phase 2a IPF Data, Outlook](https://longbridge.com/en/news/286422240.md)
- [BUZZ-Dexcom to add two directors in deal with activist Elliott; shares up](https://longbridge.com/en/news/286465778.md)